Skip to content

Dawn Health introduces Ekiva for improved disease management in paroxysmal nocturnal hemoglobinuria (PNH)

Building on their partnership announced last year, leading digital health company Dawn Health and Novartis announce the launch of Ekiva PNH. This is a digital solution for people living with paroxysmal nocturnal hemoglobinuria (PNH). This latest product launch [...]

Deepening the partnership: Dawn Health launches Ekiva for improved disease management in paroxysmal nocturnal hemoglobinuria (PNH)
author avatar
LabNews Media LLC
The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They are bestselling authors, science writers and science journalists since 1994.More details about their writing on X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu
LabNews Media LLC

LabNews Media LLC

The Editors in Chief of labnews.ai are Marita Vollborn and Vlad Georgescu. They have been bestselling authors, science writers, and science journalists since 1994.More details about their writing at X-Press Journalistenbüro (https://xpress-journalisten.com).More Info on Wikipedia:About Marita: https://de.wikipedia.org/wiki/Marita_Vollborn About Vlad: https://de.wikipedia.org/wiki/Vlad_Georgescu